Figure 1.

Trial profile. ^aParticipants could have multiple reasons for ineligibility. ^bThe most common reasons for not meeting inclusion criteria or meeting exclusion criteria are listed. All other reasons occurred in <1% of participants. ^cProtocol deviations leading to exclusion from the per-protocol population; participants could have had ≥1 reason. Abbreviations: AE, adverse event(s); ART, antiretroviral therapy; CAR, current antiretroviral regimen; DTG/3TC, dolutegravir/lamivudine.